Technical Analysis for LJPC - La Jolla Pharmaceutical Company

Grade Last Price % Change Price Change
grade B 9.76 3.50% 0.33
LJPC closed up 3.5 percent on Friday, August 16, 2019, on 56 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical LJPC trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%

Older signals for LJPC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for chronic organ failure and cancer. The company's products include GCS-100, a Phase-1/2 clinical trial drug used for the treatment of chronic kidney disease. It also provides LJPC-501, a peptide agonist of the renin-angiotensin system, which is designed to help restore kidney function in patients with hepatorenal syndrome. In addition, the company is developing LJPC-101, a subcutaneous formulation of GCS-100; LJPC-201, an oral galectin-3 inhibitor; and LJPC-301, a monoclonal antibody designed to neutralize galectin-3. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.
Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Medication Chronic Kidney Disease Peptide Hormones Proteins Lectins Galectin Galectin 3 Hepatorenal Syndrome
Is LJPC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.535
52 Week Low 5.01
Average Volume 975,111
200-Day Moving Average 8.7907
50-Day Moving Average 9.124
20-Day Moving Average 8.6695
10-Day Moving Average 8.99
Average True Range 0.5936
ADX 25.38
+DI 30.2539
-DI 10.1805
Chandelier Exit (Long, 3 ATRs ) 8.4292
Chandelier Exit (Short, 3 ATRs ) 9.5408
Upper Bollinger Band 9.6031
Lower Bollinger Band 7.7359
Percent B (%b) 1.08
BandWidth 21.537574
MACD Line 0.184
MACD Signal Line 0.0413
MACD Histogram 0.1427
Fundamentals Value
Market Cap 215.92 Million
Num Shares 22.1 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -1.91
Price-to-Sales 5475.91
Price-to-Book 5.28
PEG Ratio -0.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.90
Resistance 3 (R3) 10.92 10.57 10.71
Resistance 2 (R2) 10.57 10.28 10.56 10.65
Resistance 1 (R1) 10.16 10.10 10.37 10.14 10.58
Pivot Point 9.81 9.81 9.91 9.80 9.81
Support 1 (S1) 9.40 9.52 9.61 9.38 8.94
Support 2 (S2) 9.05 9.34 9.04 8.87
Support 3 (S3) 8.64 9.05 8.81
Support 4 (S4) 8.62